Rat cytomegalovirus induces a temporal downregulation of major histocompatibility complex class I cell surface expression

Viral Immunology

Volumn 18, Issue 4, 2005, Pages 607-615

  Hassink, Gerco C ^a   Duijvestijn Van Dam, Joanne G ^b   Koppers Lalic, Danijela ^a   Van Gaans Van Den Brink, Jacqueline ^c   Van Leeuwen, Daphne ^a   Vink, Cornelis ^b   Bruggeman, Cathrien A ^b   Wiertz, Emmanuel J H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL IMMORTALIZATION; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HERPES VIRUS; IMMUNOPRECIPITATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; RAT;

ANIMALS; ANTIGENS, SURFACE; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MUROMEGALOVIRUS; PROTEIN TRANSPORT; RATS; TIME FACTORS;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HERPESVIRIDAE; MURID HERPESVIRUS 2; MURINAE; RED CLOVER MOTTLE VIRUS;

EID: 29844447072     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.607     Document Type: Article

References (53)

1. Ahn, K., A. Angulo, P. Ghazal, P.A. Peterson, Y. Yang, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. U.S.A. 93:10990-10995.
2. Ahn, K., A. Gruhler, B. Galocha, T.R. Jones, E.J. Wiertz, H.L. Ploegh, P.A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621.
3. Bangia, N., P.J. Lehner, E.A. Hughes, M. Surman, and P. Cress well. 1999. The N-terminal region of tapasin is required to stabilize the MHC class I loading complex. Eur. J. Immunol. 29:1858-1870.
4. Barel, M.T., N. Pizzato, D. van Leeuwen, P.L. Bouteiller, E.J. Wiertz, and F. Lenfant. 2003. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation. Eur. J. Immunol. 33:1707-1716.
5. Beck, S., and B.G. Barrell. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269-272.
6. Beersma, M.F., M.J. Bijlmakers, and H.L. Ploegh. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455-4464.
7. Beisser, P.S., J.S. Kloover, G.E. Grauls, M.J. Blok, C.A. Bruggeman, and C. Vink. 2000. The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host. J. Virol. 74:1045-1050.
8. Bruggeman, C.A., W.M. Debie, G. Grauls, G. Majoor, and C.P. van Boven. 1983. Infection of laboratory rats with a new cytomegalo-like virus. Arch. Virol. 76:189-199.
9. Bruggeman, C.A., F. Li, and F.S. Stals. 1995. Pathogenicity: animal models. Scand. J. Infect. Dis. (Suppl 99):43-50.
10. Bruggeman, C.A., H. Meijer, F. Bosman, and C.P. van Boven. 1985. Biology of rat cytomegalovirus infection. Intervirology 24:1-9.
11. Bruning, J.H., W.H. Debie, P.H. Dormans, H. Meijer, and C.A. Bruggeman. 1987. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch. Virol. 94:55-70.
12. Campbell, A.E., and J.S. Slater. 1994. Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. I. Virol. 68:1805-1811.
13. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M.L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282.
14. Cretney, E., M.A. Degli-Esposti, E.H. Densley, H.E. Farrell, N.J. Davis-Poynter, and M.J. Smyth. 1999. m144, a Murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190:435-444.
15. Del Val, M., H. Hengel, H. Hacker, U. Hartlaub, T. Ruppert, P. Lucin, and U.H. Koszinowski. 1992. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176:729-738.
16. Fahnestock, M.L., J.L. Johnson, R.M. Feldman, J.M. Neveu, W.S. Lane, and P.J. Bjorkman. 1995. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583-590.
17. Farrell, H.E., M.A. Degli-Esposti, and N.J. Davis-Poynter. 1999. Cytomegalovirus evasion of natural killer cell responses. Immunol. Rev. 168:187-197.
18. Farrell, H.E., H. Vally, D.M. Lynch, P. Fleming, G.R. Shellam, A.A. Scalzo, and N.J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510-514.
19. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P.M. van Endert, R. Tampe, P.A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418.
20. Fukumoto, T., W.R. McMaster, and A.F. Williams. 1982. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur. J. Immunol. 12:237-243.
21. Haagmans, B.L., P.H. van der Meide, F.S. Stals, A.J. van den Eertwegh, E. Claassen, C.A. Bruggeman, M.C. Horzinek, and V.E. Schijns. 1994. Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J. Virol. 68:2305-2312.
22. Hengel, H., J.O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G.J. Hammerling, U.H. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623-632.
23. Hengel, H., U. Reusch, A. Gutermann, H. Ziegler, S. Jonjic, P. Lucin, and U.H. Koszinowski. 1999. Cytomegaloviral control of MHC class I function in the mouse. Immunol. Rev. 168:167-176.
24. Hewitt, E.W., S.S. Gupta, and P.J. Lehner. 2001. The human cytomegalovirus gene product US6 inhibits ATP binding ty TAP. EMBO J. 20:387-396.
25. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415.
26. Hudson, J.B. 1988. Further studies on the mechanism of centrifugal enhancement of cytomegalovirus infectivity. J. Virol. Methods 19:97-108.
27. Hughes, E.A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. U.S.A. 94:1896-1901.
28. Jones, T.R., L.K. Hanson, L. Sun, J.S. Slater, R.M. Stenberg, and A.E. Campbell. 1995. Multiple independnet loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830-4841.
29. Jones, T.R., and L. Sun. 1997. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:2970-2979.
30. Jones, T.R., E.J. Wiertz, L. Sun, K.N. Fish, J.A. Nelson, and H.L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U.S.A. 93:11327-11333.
31. Kavanagh, D.G., M.C. Gold, M. Wagner, U.H. Koszinowski, and A.B. Hill. 2001. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194: 967-978.
32. Kavanagh, D.G., U.H. Koszinowski, and A.B. Hill. 2001. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J. Immunol. 167:3894-3902.
33. Kleijnen, M.F., J.B. Huppa, P. Lucin, S. Mukherjee, H. Farrell, A.E. Campbell, U.H. Koszinowski, A.B. Hill, and H.L. Ploegh. 1997. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16:685-694.
34. Kyritsis, C., S. Gorbulev, S. Hutschenreiter, K. Pawlitschko, R. Abele, and R. Tampe. 2001. Molecular mechanism and structural aspect of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem. 276:48031-48039.
35. Lee, S., J. Yoon, B. Park, Y. Jun, M. Jin, H. C. Sung, I.H. Kim, S. Kang, E.J. Choi, B.Y. Ahn, and K. Ahn. 2000. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. J. Virol. 74:11262-11269.
36. LoPiccolo, D.M., M.C. Gold, D.G. Kavanagh, M. Wagner, U.H. Koszinowski, and A.B. Hill. 2003. Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J. Virol. 77:301-308.
37. Park, B., Y. Kim, J. Shin, S. Lee, K. Cho, K. Fruh, S. Lee, and K. Ahn. 2004. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20:71-85.
38. Price, P., and S.D. Olver. 1996. Syndromes induced by cytomegalovirus infection. Clin. Immunol. Immunopathol. 80:215-224.
39. Reits, E.A., J.C. Vos, M. Gromme, and J. Neefjes. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774-778.
40. Reusch, U., W. Muranyi, P. Lucin, H.G. Burgert, H. Hengel, and U.H. Koszinowski. 1999. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18:1081-1091.
41. Rock, K.L., and A.L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739-779.
42. Schubert, U., L.C. Anton, J. Gibbs, C.C. Norbury, J.W. Yewdell, and J.R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-774.
43. Stals, F.S., F. Bosman, C.P. van Boven, and C.A. Bruggeman. 1990. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch. Virol. 114:91-107.
44. Tortorella, D., B.E. Gewurz, M.H. Furman, D.J. Schust, and H.L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926.
45. Vink, C., E. Beuken, and C.A. Bruggeman. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
46. Vitale, M., R. Castriconi, S. Parolini, D. Pende, M.L. Hsu, L. Moretta, D. Cosman, and A. Moretta. 1999. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Int. Immunol. 11:29-35.
47. Vossen, M.T., E.M. Westerhout, C. Soderberg-Naucler, and E.J. Wiertz. 2002. Viral immune evasion: a master-piece of evolution. Immunogenetics 54:527-542.
48. Vossen, R.C., M.C. Persoons, M.E. Slobbe-van Drunen, C.A. Bruggeman, and M.C. Dam-Mieras. 1997. Intracellular thiol redox status affects rat cytomegalovirus infection of vascular cells. Virus Res. 48:173-183.
49. Warren, A.P., D.H. Ducroq, P.J. Lehner, and L.K. Borysiewicz. 1994. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68:2822-2829.
50. Wiertz, E.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.
51. Wiertz, E.J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones, T.A. Rapoport, and H.L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432-438.
52. Ziegler, H., W. Muranyi, H.G. Burgert, E. Kremmer, and U.H. Koszinowski. 2000. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 19:870-881.
53. Ziegler, H., R. Thale, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U.H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57-66.